Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. Announce...
NEW BRUNSWICK, N.J. (January 7, 2016) – Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. read more
View ArticleNew hepatitis data highlight need for urgent global response
New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. read more
View ArticleNews Release: Promising New Drug for Hepatitis B Tested First at Texas...
Robert Lanford, Ph.D., Director of SNPRC in his laboratory.San Antonio, Texas (November 7, 2017) – Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical...
View ArticleMethod reveals how hidden DNA mutations affect tissues
In a development with implications for better understanding disease, researchers have created a computational system to predict the effect that mutations in noncoding DNA — sections that don’t produce...
View ArticleVirion Therapeutics, LLC Raises $5 Million to Develop Checkpoint Inhibitor...
PHILADELPHIA — (Sept. 26, 2018) — A new Philadelphia-based start-up, Virion Therapeutics, LLC spun out of The Wistar Institute, will work to advance innovative, immune-based therapies for the treatment...
View Article
